The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to UC Francisco researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.
Harnessing molecular diagnostics to address antibiotic shortages
Editor’s Note: David Persing, chief medical and scientific officer at Cepheid, a Danaher operating company, is an expert on molecular diagnostics and anti-microbial resistance. He has spent
August 22, 2023